|
Report ID
|
93479 |
|
Drug Identification Number
|
02473968 |
|
Brand name
|
ODAN-SODIUM POLYSTYRENE SULFONATE |
|
Common or Proper name
|
Sodium Polystyrene Sulfonate Oral/Rectal Suspension |
|
Company Name
|
ODAN LABORATORIES LTD |
|
Market Status
|
MARKETED |
|
Active Ingredient(s)
|
SODIUM POLYSTYRENE SULFONATE |
|
Strength(s)
|
250MG |
|
Dosage form(s)
|
SUSPENSION |
|
Route of administration
|
ORAL
RECTAL |
|
Packaging size
|
500 mL |
|
ATC code
|
V03AE |
|
ATC description
|
ALL OTHER THERAPEUTIC PRODUCTS |
|
Reason for shortage
|
Disruption of the manufacture of the drug. |
|
Anticipated start date
|
|
|
Actual start date
|
2019-09-01 |
|
Estimated end date
|
2023-10-25 |
|
Actual end date
|
2023-10-04 |
|
Shortage status
|
Resolved |
|
Updated date
|
2023-10-05 |
|
Company comments
|
|
|
Health Canada comments
|
|
|
Tier 3 Status
|
No |
| Company contact information |
[email protected]
Tel.: 1-800-387-9342
Fax: 1-800-329-6326 |
